Table 1 Key informant interview guide and questions mapped onto CFIR domains
CFIR domain(s) | Core questions | Prompts |
|---|---|---|
Intervention characteristics—evidence strength and quality; relative advantage | 1. What are your views on using self-collected HPV testing as a potential option for cervical cancer screening? | Would you like to have it as an option you could offer patients? Why or why not? Do you see any other particular advantages or disadvantages to HPV self-sampling? |
Intervention characteristics—evidence strength and quality; relative advantage | 2. In your view, what do you think patients would think of self-collected HPV testing as an option for cervical cancer screening? | What about the patients who participate less? |
Intervention characteristics—adaptability | 3. Do you think a mailed HPV self-sampling intervention would work within the context of your clinical setting? Why or why not? | What kinds of changes or alterations do you think will need to be made to mailed HPV self-sampling so that it will work effectively in your setting? |
Intervention characteristics—adaptability | 4. HPV self-sampling could also be completed in the clinic during a clinic visit. Do you think an in-clinic HPV self-sampling intervention would work within the context of your clinical setting? Why or why not? | What kinds of changes do you think will need to be made to clinic-based HPV self-sampling so that it will work effectively in your setting? |
Inner setting—HPV self-sampling awareness | 5. Have you heard about self-collected HPV testing as an option for cervical cancer screening? | |
Inner setting—implementation climate (subconstruct—compatibility) | 6. How well would a mail-based HPV self-sampling intervention fit with existing work processes and practices in your setting? | Can you describe how mail-based HPV self-sampling would best be integrated into current processes? |
Inner setting—implementation climate (subconstruct—compatibility) | 7. How well would a clinic-based HPV self-sampling intervention fit with existing work processes and practices in your setting? | Can you describe how clinic-based HPV self-sampling would best be integrated into current processes? |
Inner setting—readiness for implementation (subconstruct—access to knowledge and information) | 8. What kind of information do you think decision-makers would need if they were to consider implementing HPV self-sampling? | |
Process—engaging (subconstruct—opinion leaders) | 9. Who are the key decision makers that would influence if HPV self-sampling would be used in your clinical context? | Do you know if your health system has discussed adopting this new method for cervical cancer screening? Why or why not? |